Concepedia

Publication | Closed Access

9176 Biomarker analyses from SATURN, a phase III placebo-controlled study of erlotinib as first-line maintenance therapy for advanced NSCLC

DOI

13

Citations

0

References

2009

Year

W. Brugger, J.-H. Kim, Olfred Hansen, R. Sulllivan, Shane White, J.-S. Lee, Mariette Schlegel, Julie Noe, Iris Nagelmeier, Federico Cappuzzo
European Journal of Cancer Supplements

No additional data available for this publication yet. Check back later!